BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 16531613)

  • 1. Homocysteine lowering with folic acid and B vitamins in vascular disease.
    Lonn E; Yusuf S; Arnold MJ; Sheridan P; Pogue J; Micks M; McQueen MJ; Probstfield J; Fodor G; Held C; Genest J;
    N Engl J Med; 2006 Apr; 354(15):1567-77. PubMed ID: 16531613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
    Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
    N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
    Mann JF; Sheridan P; McQueen MJ; Held C; Arnold JM; Fodor G; Yusuf S; Lonn EM;
    Nephrol Dial Transplant; 2008 Feb; 23(2):645-53. PubMed ID: 18003666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
    Lan X; Dang SN; Zhao YL; Yan H; Yan H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1028-34. PubMed ID: 27453118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
    JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
    Lonn E; Held C; Arnold JM; Probstfield J; McQueen M; Micks M; Pogue J; Sheridan P; Bosch J; Genest J; Yusuf S;
    Can J Cardiol; 2006 Jan; 22(1):47-53. PubMed ID: 16450017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ; Solà I; Lathyris D; Dayer M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006612. PubMed ID: 28816346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
    ; Armitage JM; Bowman L; Clarke RJ; Wallendszus K; Bulbulia R; Rahimi K; Haynes R; Parish S; Sleight P; Peto R; Collins R
    JAMA; 2010 Jun; 303(24):2486-94. PubMed ID: 20571015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine trials--clear outcomes for complex reasons.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(15):1629-32. PubMed ID: 16531615
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation.
    Hirsch S; Pia De la Maza M; Yañez P; Glasinovic A; Petermann M; Barrera G; Gattas V; Escobar E; Bunout D
    Clin Cardiol; 2002 Nov; 25(11):495-501. PubMed ID: 12430779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Combination Folic Acid, Vitamin B
    Stone KL; Lui LY; Christen WG; Troen AM; Bauer DC; Kado D; Schambach C; Cummings SR; Manson JE
    J Bone Miner Res; 2017 Dec; 32(12):2331-2338. PubMed ID: 29244251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate therapy and in-stent restenosis after coronary stenting.
    Lange H; Suryapranata H; De Luca G; Börner C; Dille J; Kallmayer K; Pasalary MN; Scherer E; Dambrink JH
    N Engl J Med; 2004 Jun; 350(26):2673-81. PubMed ID: 15215483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke.
    Liu X; Shi M; Xia F; Han J; Liu Z; Wang B; Yang F; Li L; Wu S; Wang L; Liu N; Lv Y; Zhao G
    Int J Stroke; 2015 Feb; 10(2):264-8. PubMed ID: 23490255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for lowering plasma homocysteine levels in dialysis patients.
    Nigwekar SU; Kang A; Zoungas S; Cass A; Gallagher MP; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GF; Jardine MJ
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004683. PubMed ID: 27243372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.
    Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
    JAMA; 2002 Aug; 288(8):973-9. PubMed ID: 12190367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of folic acid and vitamins B6 and B12 on microcirculatory vasoreactivity in patients with hyperhomocysteinemia.
    Abularrage CJ; Sidawy AN; White PW; Aidinian G; Dezee KJ; Weiswasser JM; Arora S
    Vasc Endovascular Surg; 2007; 41(4):339-45. PubMed ID: 17704338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.